Liposome Adjuvants: Simultaneous Induction of Innate and Adaptive Immunity is Key to Success


availability of a variety of lipids and to accommodate different types of antigens/immunomodulators [2,6]. While liposomes have initially reached the market as drug carriers, their potential as potent vaccine adjuvants has been demonstrated against several diseases such as HIV [7] tuberculosis [8], malaria [9] and leishmaniosis [10] indicating that… (More)


1 Figure or Table